Clovis Oncology Inc (NASDAQ:CLVS)

5.87
Delayed Data
As of May 14
 +0.245 / +4.36%
Today’s Change
4.08
Today|||52-Week Range
11.10
+22.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Operating ActivitiesNet Income / Starting Line-89.9M-99.3M-86.4M-120.4M
 
 
 
 
 
Depreciation990.0K2.1M1.7M1.9M
 
 
 
 
 
Total Other Cash Flow12.0M12.3M14.2M34.7M
 
 
 
 
 
Funds From Operations-76.9M-84.9M-70.5M-83.8M
 
 
 
 
 
Funds From/For Other Operating Expenses-4.5M-2.1M27.9M14.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-72.4M-82.7M-98.5M-98.0M
 
 
 
 
 
 
InvestingIncrease In Investments-195.0M-180.0M-138.4M-67.4M
 
 
 
 
 
Decrease In Investments95.0M195.0M153.5M143.3M
 
 
 
 
 
Capital Expenditures-5.6M-1.5M-1.2M-253.0K
 
 
 
 
 
Net Cash Flow Investing-105.6M13.5M-1.1M75.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00-245.0K0.000.00
 
 
Long Term Borrowings-148.0K0.000.006.9M
 
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale740.0K770.0K1.1M1.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.0035.0K0.000.00
 
 
Net Cash Flow - Financing592.0K490.0K1.1M8.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-79.0K-261.0K-64.0K107.0K
 
 
 
 
 
 
Net Change In Cash-177.4M-68.7M-98.5M-14.8M